drug industry

0 PATH & Sanofi start major production of synthetic anti-malaria drug

Malaria remains one of the world’s biggest killers and also a massive economic drag on poor countries, poor families. One of our best weapons against this scourge is a drug known as artemisinin, which is harvested from the plant sweet wormwood and, as a crop, is about as predictable as corn or hog futures.A major new initiative to be launched tomorrow in Italy by Seattle-based PATH in collaboration with the French drug maker Sanofi aims to do industrial production of synthetic artemisinin.

0 Drug industry loses in India – fight over ‘patents vs poor’ to continue

The Indian Supreme Court has rejected a drug patent application by the international pharmaceutical firm Novartis, an event that merited coverage by the New York Times, BBC and many other media – news which you might think is mostly a matter for the business page or drug industry insiders. In fact, the case may represent one of the most difficult dilemmas in global health. It is a fight that is far from over.